2012
DOI: 10.5935/1808-8694.20120007
|View full text |Cite
|
Sign up to set email alerts
|

The use of Mitomycin-C to reduce synechia in middle meatus in sinus surgery: preliminary results

Abstract: Mitomycin C was not effective in preventing middle meatus synechia, but reduced the probability of total synechia formation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(23 citation statements)
references
References 28 publications
0
22
1
Order By: Relevance
“…Characteristics of the included studies are described in Table . Among 11 trials, 10 were paired designs, in which each patient received two treatments (bilateral sinusitis) and only one trial was a parallel RCT (unilateral sinusitis). Most trials had a percentage of male patients ranged from 47% to 70%.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Characteristics of the included studies are described in Table . Among 11 trials, 10 were paired designs, in which each patient received two treatments (bilateral sinusitis) and only one trial was a parallel RCT (unilateral sinusitis). Most trials had a percentage of male patients ranged from 47% to 70%.…”
Section: Resultsmentioning
confidence: 99%
“…Mitomycin C or saline solution was applied after endoscopic sinus surgery. The concentrations of Mitomycin C used were 0.4, 0.45, 0.5, 0.8, and 1.0 mg/mL with a volume of 1, 1.5, and 5 mL . The application time ranged from 4 to 5 min.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Synechia formation between the MT and the lateral nasal wall after ESS and subsequent lateralization of the MT can trigger recurrent CRS. It is thus essential to preserve the mucosa by performing ESS gently . However, mucosal tearing and bone exposure cannot be completely avoided.…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, mitomycin C, an antiproliferative agent with inhibitory effects on fibroblasts, has also been suggested. 26 Mitomycin C has been shown to decrease scar formation in several procedures [27][28][29] and appears to be effective in helping to treat esophageal strictures. 30,31 Vanni et al 13 recently reported the use of mitomycin C in conjunction with TUIAS for treatmentresistant strictures for which prior dilation and TUIAS had failed.…”
Section: Dilationmentioning
confidence: 99%